Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

ClinicalTrials.gov ID: NCT00999167

Public ClinicalTrials.gov record NCT00999167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2 study of HPN-100 in subjects with hepatic encephalopathy (HE) consisting of an open label safety lead-in (Part A), followed by randomized, double-blind, placebo-controlled treatment (Part B).

Study identification

NCT ID
NCT00999167
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2009 (Type not available)
Primary completion
Apr 2012 (Actual)
Completion
Apr 2012 (Actual)
Last update posted
Jul 10, 2024

2009 – 2012

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
24
Facility City State ZIP Site status
Stanford University Medical Center, Division of Gastroenterology and Hepatology Palo Alto California 94304 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
University of Miami / Center for Liver Diseases Miami Florida 33136 —
Tampa General Hospital Tampa Florida 33606 —
The University of Chicago Medical Center Chicago Illinois 60637 —
Indiana University Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Tulane University Health Science Center New Orleans Louisiana 70112 —
University of Maryland Baltimore Maryland 21201 —
Henry Ford Hospital / Department of Gastroenterology Detroit Michigan 48202 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Concorde Medical Group PLLC New York New York 10016 —
NYU Medical Center New York New York 10016 —
Mount Sinai Medical Center New York New York 10029 —
Columbia University Medical Center / Center for Liver Disease and Transplantation New York New York 10032 —
University of Rochester Medical Center Rochester New York 14642 —
New York Medical College / Westchester Medical Center Valhalla New York 10595 —
University of Cincinnati / Division of Digestive Diseases Cincinnati Ohio 45267 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
The Digestive Disease Center at Vanderbilt Nashville Tennessee 37232 —
Methodist Dallas Medical Center Dallas Texas 75203 —
UT Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine-St. Luke's Episcopal Hospital Houston Texas 77030 —
University of Virginia Health System Charlottesville Virginia 22908 —
University of Wisconsin Hospital & Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00999167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00999167 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →